NCT04501120 2025-09-26Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AMLAscentage Pharma Group Inc.Phase 1/2 Recruiting458 enrolled
NCT04964518 2023-10-25A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)Ascentage Pharma Group Inc.Phase 1/2 Unknown24 enrolled